Pulmonary arterial hypertension and pregnancy

dc.contributor.authorTerek, Demet
dc.contributor.authorKayikcioglu, Meral
dc.contributor.authorKultursay, Hakan
dc.contributor.authorErgenoglu, Mete
dc.contributor.authorYalaz, Mehmet
dc.contributor.authorMusayev, Oktay
dc.contributor.authorMogulkoc, Nesrin
dc.contributor.authorGunusen, Ilkben
dc.contributor.authorAkisu, Mete
dc.contributor.authorKultursay, Nilgun
dc.date.accessioned2019-10-27T21:43:22Z
dc.date.available2019-10-27T21:43:22Z
dc.date.issued2013
dc.departmentEge Üniversitesien_US
dc.description.abstractThis is the case report of a pregnant woman who refused pregnancy termination when diagnosed with pulmonary arterial hypertension (PAH) functional class 2-3 at the 24th week of gestation and of her newborn. A pregnant woman with PAH functional class 2-3 was treated with inhaled prostacyclin analog ( iloprost), oral sildenafil, oxygen, and low molecular weight heparin. She delivered at 32nd week by Cesarean section. The infant required oxygen up to 36th week postconceptional age and had a short steroid treatment. The mother needed close cardiovascular monitorization, intensive oxygen and pulmonary vasodilator therapy for 2 months and was discharged with oxygen and oral iloprost treatment. A multidisciplinary approach together with pulmonary vasodilator therapy may be succesful in such a high-risk pregnant woman.en_US
dc.identifier.endpage76en_US
dc.identifier.issn1735-1995
dc.identifier.issn1735-7136
dc.identifier.issue1en_US
dc.identifier.pmid23900530en_US
dc.identifier.startpage73en_US
dc.identifier.urihttps://hdl.handle.net/11454/47073
dc.identifier.volume18en_US
dc.identifier.wosWOS:000317860700016en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofJournal of Research in Medical Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectIloprosten_US
dc.subjectnewbornen_US
dc.subjectpregnancyen_US
dc.subjectpulmonary hypertensionen_US
dc.subjectsildenafilen_US
dc.subjectsurvivalen_US
dc.subjecttherapyen_US
dc.titlePulmonary arterial hypertension and pregnancyen_US
dc.typeArticleen_US

Dosyalar